1050 / 1708
AREN0532- Stage III FH
N EFS P value OS P value
Lymph nodes
Negative
237 95% < 0.01 98% 0.18
Positive
152 83%
95%
Gross residual
disease
Negative
394 89% 0.14 97% 0.39
Positive
134 85%
93%
LOH
Neither
382 92% < 0.01 97% 0.55
16q only
99 83%
97%
1p only
56 74%
93%
Fernandez CV et al. J Clin Oncol 33 (suppl; abstr 10010)
The 4-year EFS and OS estimates were 88% and 96% respectively